Companies › ONCO
Onconetix Inc (ONCO)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001782107 · EDGAR filings · Updated 2026-07-27
Onconetix Inc (ONCO) has reported institutional ownership of 0.5%, with 5 institutional managers holding positions valued at $24.9K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (1)
- 2026-07-27 — SCHEDULE 13G filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-07 — 425 filed
- 2026-06-24 — 425 filed
- 2026-06-17 — Prospectus supplement (424B3) filed
- 2026-06-16 — EFFECT filed
- 2026-06-09 — Registration statement (S-1) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Onconetix Inc has 5 institutional holders and institutional ownership of 0.5%.
Insider activity
Insiders reported 9 transactions (0 buys, 0 sells) across 5 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
PRF TECHNOLOGIES LTD (PRFX) · AKANDA CORP (AKAN) · CUPRINA HLDGS (CAYMAN) LTD (CUPR) · EUDA HEALTH HOLDINGS LTD (EUDA) · BON NATURAL LIFE LIMITED (BON) · ADITXT INC (ADTX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.